Halifax-based MedMira begins full clinical trials for its comprehensive syphilis test in partnership with St. Michael's Hospital and funded by CIHR.

MedMira Inc., a Halifax-based company, is set to conduct full clinical trials for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test. This rapid point-of-care (POC) test combines screening and confirmation in a single high-quality test, providing a comprehensive solution for detecting active syphilis infections. The trials, in partnership with REACH Nexus at St. Michael's Hospital's MAP Centre for Urban Health Solutions and funded by the Canadian Institute of Health Research (CIHR), aim to address the increasing need for flexible, accurate, and cost-effective detection of syphilis infections.

August 13, 2024
7 Articles